Annual EBITDA
-$7.49 M
+$43.80 K+0.58%
June 1, 2024
Summary
- As of February 12, 2025, GENE annual EBITDA is -$7.49 million, with the most recent change of +$43.80 thousand (+0.58%) on June 1, 2024.
- During the last 3 years, GENE annual EBITDA has fallen by -$2.51 million (-50.40%).
- GENE annual EBITDA is now -668.05% below its all-time high of $1.32 million, reached on June 30, 2008.
Performance
GENE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
N/A
June 1, 2024
Summary
- GENE quarterly EBITDA is not available.
Performance
GENE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
N/A
June 1, 2024
Summary
- GENE TTM EBITDA is not available.
Performance
GENE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GENE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.6% | - | - |
| 3 y3 years | -50.4% | - | - |
| 5 y5 years | -63.5% | - | - |
GENE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.3% | +0.6% | ||||
| 5 y | 5-year | -87.2% | +0.6% | ||||
| alltime | all time | -668.0% | +21.6% |
Genetic Technologies Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | -$7.49 M(-0.6%) | - | - |
| Jun 2023 | -$7.54 M(+58.2%) | - | - |
| Jun 2022 | -$4.76 M(-4.4%) | - | - |
| Jun 2021 | -$4.98 M(+24.5%) | - | - |
| Jun 2020 | -$4.00 M(-12.6%) | - | - |
| Jun 2019 | -$4.58 M(+8.9%) | - | - |
| Jun 2018 | -$4.21 M(-33.4%) | - | - |
| Jun 2017 | -$6.31 M(+2.8%) | - | - |
| Jun 2016 | -$6.14 M(-14.2%) | - | - |
| Jun 2015 | -$7.15 M(-17.0%) | - | - |
| Jun 2014 | -$8.62 M(-9.8%) | - | - |
| Jun 2013 | -$9.56 M(+76.5%) | - | - |
| Jun 2012 | -$5.42 M(-671.9%) | - | - |
| Jun 2011 | $947.20 K(-111.1%) | - | - |
| Jun 2010 | -$8.56 M(+169.7%) | - | - |
| Jun 2009 | -$3.17 M(-340.5%) | - | - |
| Jun 2008 | $1.32 M | -$14.81 M(-346.9%) | -$4.05 M(-222.9%) |
| Mar 2008 | - | $6.00 M(+488.5%) | $3.29 M(+426.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | - | $1.02 M(-72.8%) | $625.00 K(-143.3%) |
| Sep 2007 | - | $3.75 M(-150.1%) | -$1.44 M(-54.0%) |
| Jun 2007 | $124.70 K(-103.9%) | -$7.47 M(-324.2%) | -$3.14 M(-47.9%) |
| Mar 2007 | - | $3.33 M(-418.1%) | -$6.03 M(-19.2%) |
| Dec 2006 | - | -$1.05 M(-151.1%) | -$7.46 M(+13.1%) |
| Sep 2006 | - | $2.05 M(-119.8%) | -$6.59 M(+8.5%) |
| Jun 2006 | -$3.19 M(-31.8%) | -$10.36 M(-645.5%) | -$6.08 M(-37.7%) |
| Mar 2006 | - | $1.90 M(-1145.2%) | -$9.75 M(+9.7%) |
| Dec 2005 | - | -$181.70 K(-107.1%) | -$8.89 M(+0.5%) |
| Sep 2005 | - | $2.56 M(-118.3%) | -$8.85 M(+1.2%) |
| Jun 2005 | -$4.68 M(-6.6%) | -$14.03 M(-608.4%) | -$8.74 M(-265.3%) |
| Mar 2005 | - | $2.76 M(-2047.9%) | $5.29 M(+109.1%) |
| Dec 2004 | - | -$141.70 K(-105.3%) | $2.53 M(-5.3%) |
| Sep 2004 | - | $2.67 M | $2.67 M |
| Jun 2004 | -$5.02 M(+4667.9%) | - | - |
| Jun 2003 | -$105.20 K(-92.5%) | - | - |
| Jun 2002 | -$1.41 M(-41.2%) | - | - |
| Jun 2001 | -$2.39 M(+51.2%) | - | - |
| Jun 2000 | -$1.58 M | - | - |
FAQ
- What is Genetic Technologies Limited annual EBITDA?
- What is the all time high annual EBITDA for Genetic Technologies Limited?
- What is Genetic Technologies Limited annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for Genetic Technologies Limited?
- What is the all time high TTM EBITDA for Genetic Technologies Limited?
What is Genetic Technologies Limited annual EBITDA?
The current annual EBITDA of GENE is -$7.49 M
What is the all time high annual EBITDA for Genetic Technologies Limited?
Genetic Technologies Limited all-time high annual EBITDA is $1.32 M
What is Genetic Technologies Limited annual EBITDA year-on-year change?
Over the past year, GENE annual EBITDA has changed by +$43.80 K (+0.58%)
What is the all time high quarterly EBITDA for Genetic Technologies Limited?
Genetic Technologies Limited all-time high quarterly EBITDA is $6.00 M
What is the all time high TTM EBITDA for Genetic Technologies Limited?
Genetic Technologies Limited all-time high TTM EBITDA is $5.29 M